We only have this paper's title and publication details.
Read it at the sourceAnalysis shows evolving mutational signatures in intestinal metaplasia and gastric cancer, indicating progression risks.
Overview of mutational signature analysis across IM and GC.
No takes yet. Share an insight, caveat, or question.
Xu et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: